Synthesis and biological activity of novel tert-amylphenoxyalkyl (homo)piperidine derivatives as histamine H3R ligands. Issue 10 (15th May 2017)
- Record Type:
- Journal Article
- Title:
- Synthesis and biological activity of novel tert-amylphenoxyalkyl (homo)piperidine derivatives as histamine H3R ligands. Issue 10 (15th May 2017)
- Main Title:
- Synthesis and biological activity of novel tert-amylphenoxyalkyl (homo)piperidine derivatives as histamine H3R ligands
- Authors:
- Kuder, Kamil J.
Łażewska, Dorota
Kaleta, Maria
Latacz, Gniewomir
Kottke, Tim
Olejarz, Agnieszka
Karcz, Tadeusz
Fruziński, Andrzej
Szczepańska, Katarzyna
Karolak-Wojciechowska, Janina
Stark, Holger
Kieć-Kononowicz, Katarzyna - Abstract:
- Graphical abstract: Highlights: Series of twenty tert -amyl phenoxyalkylamine derivatives (2 –21 ) was synthesized. Compounds evaluated at hH3 R in binding affinity tests demonstrated K i values at 8.8–325 nM range. Anticonvulsant activity at MES, scMet and neurotoxicity tests were evaluated for selected compounds. X-ray structure analysis of compound18 was performed. Molecular modeling was performed and "drug-like" properties were estimated. Abstract: As a continuation of our search for novel histamine H3 receptor ligands a series of twenty new tert -amyl phenoxyalkylamine derivatives (2 –21 ) was synthesized. Compounds of four to eight carbon atoms spacer alkyl chain were evaluated on their binding properties at human histamine H3 receptor (hH3 R). The highest affinities were observed for pentyl derivatives6 –8 ( K i = 8.8–23.4 nM range) and among them piperidine derivative6 with K i = 8.8 nM. Structures6, 7 were also classified as antagonists in cAMP accumulation assay (with EC50 = 157 and 164 nM, respectively). Moreover, new compounds were also evaluated for anticonvulsant activity in Antiepileptic Screening Program (ASP) at National Institute of Neurological Disorders and Stroke (USA). Seven compounds (2 –4, 9, 11, 12 and20 ) showed anticonvulsant activity at maximal electroshock (MES) test in the dose of 30 mg/kg at 0.5 h. In the subcutaneous pentetrazole (scMET) test compound4 showed protection at 100 and 300 mg/kg dose at mice, however compounds showed highGraphical abstract: Highlights: Series of twenty tert -amyl phenoxyalkylamine derivatives (2 –21 ) was synthesized. Compounds evaluated at hH3 R in binding affinity tests demonstrated K i values at 8.8–325 nM range. Anticonvulsant activity at MES, scMet and neurotoxicity tests were evaluated for selected compounds. X-ray structure analysis of compound18 was performed. Molecular modeling was performed and "drug-like" properties were estimated. Abstract: As a continuation of our search for novel histamine H3 receptor ligands a series of twenty new tert -amyl phenoxyalkylamine derivatives (2 –21 ) was synthesized. Compounds of four to eight carbon atoms spacer alkyl chain were evaluated on their binding properties at human histamine H3 receptor (hH3 R). The highest affinities were observed for pentyl derivatives6 –8 ( K i = 8.8–23.4 nM range) and among them piperidine derivative6 with K i = 8.8 nM. Structures6, 7 were also classified as antagonists in cAMP accumulation assay (with EC50 = 157 and 164 nM, respectively). Moreover, new compounds were also evaluated for anticonvulsant activity in Antiepileptic Screening Program (ASP) at National Institute of Neurological Disorders and Stroke (USA). Seven compounds (2 –4, 9, 11, 12 and20 ) showed anticonvulsant activity at maximal electroshock (MES) test in the dose of 30 mg/kg at 0.5 h. In the subcutaneous pentetrazole (scMET) test compound4 showed protection at 100 and 300 mg/kg dose at mice, however compounds showed high neurotoxicity in rotarod test at used doses. Also, molecular modeling studies were undertaken, to explain affinity of compounds at hH3 R (taking into the consideration X-ray analysis of compound18 ). In order to estimate "drug-likeness" of selected compounds in silico and experimental evaluation of lipophilicity, metabolic stability and cytotoxicity was performed. … (more)
- Is Part Of:
- Bioorganic & medicinal chemistry. Volume 25:Issue 10(2017)
- Journal:
- Bioorganic & medicinal chemistry
- Issue:
- Volume 25:Issue 10(2017)
- Issue Display:
- Volume 25, Issue 10 (2017)
- Year:
- 2017
- Volume:
- 25
- Issue:
- 10
- Issue Sort Value:
- 2017-0025-0010-0000
- Page Start:
- 2701
- Page End:
- 2712
- Publication Date:
- 2017-05-15
- Subjects:
- Histamine H3 receptor -- Histamine H3 receptor ligands -- Non-imidazole histamine H3R ligands -- Piperidine derivatives -- Anticonvulsants -- Molecular docking -- Drug-like properties
NLVYWCRLGFDESU-UHFFFAOYSA-N -- CUKJWVHEMLBESD-UHFFFAOYSA-N -- POQQPNLUXGVXQL-UHFFFAOYSA-N -- WUWSDBLNZJIRHW-UHFFFAOYSA-N -- ZTNOXDYSIFPOBI-UHFFFAOYSA-N -- NABGTSWKHZDURR-UHFFFAOYSA-N -- QHLCQRLEFPCFJI-UHFFFAOYSA-N -- NTMAHDOXEBKVCH-UHFFFAOYSA-N -- QGGWOUVIJJJJEP-UHFFFAOYSA-N -- ZNIBZXYWEHLBPD-UHFFFAOYSA-N -- UESFTYGAZXOTRU-UHFFFAOYSA-N -- AYKJGACMCQMMAW-UHFFFAOYSA-N -- NVODSBDSTGAOMT-UHFFFAOYSA-N -- FWWPKYOBCUXAGM-UHFFFAOYSA-N -- OGOMRHOWEGLGBX-UHFFFAOYSA-N -- VYNGDPLRECMOSF-UHFFFAOYSA-N -- MKYGVSXNJQDMLW-UHFFFAOYSA-N -- GBEKSZVQFLMGCF-UHFFFAOYSA-N -- HZDUQTXNWTWVGF-UHFFFAOYSA-N -- OCDZXKYOYHCDPQ-UHFFFAOYSA-N -- LAKVEWGOEMZVEF-UHFFFAOYSA-N
Bioorganic chemistry -- Periodicals
Pharmaceutical chemistry -- Periodicals
Biochemistry -- Periodicals
Chemistry, Clinical -- Periodicals
Chemistry, Organic -- Periodicals
Chimie bio-organique -- Périodiques
Chimie pharmaceutique -- Périodiques
615.19 - Journal URLs:
- http://www.sciencedirect.com/science/journal/09680896 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.bmc.2017.03.031 ↗
- Languages:
- English
- ISSNs:
- 0968-0896
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2089.325000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 1216.xml